Literature DB >> 3276167

The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program.

S P Cooper1, R J Hardy, D R Labarthe, C M Hawkins, E O Smith, M D Blaufox, C J Cooper, G Entwisle, M H Maxwell.   

Abstract

The relation between degree of diastolic blood pressure reduction and mortality was examined among hypertensive persons in the Hypertension Detection and Follow-up Program. This program, conducted from 1973-1979, was a multicenter community-based trial, which followed 10,940 hypertensive participants for five years. The one-year annual visit was the first occasion on which change in blood pressure could be measured on all participants. During the subsequent four years of follow-up on 10,053 participants, 568 deaths occurred. With time-dependent life tables and time-dependent Cox life table regression analyses, the existence of a quadratic function which modeled the relation between diastolic blood pressure reduction and mortality was supported, even after adjusting for other risk factors. The minimum mortality hazard ratio, based on a particular model, occurred at a diastolic blood pressure reduction of 26.2 mmHg (standard error = 13.4) in the whole population and 10.0 mmHg (standard error = 5.3) in the baseline diastolic blood pressure stratum 90-104 mmHg. After this reduction, there was a small increase in the risk of death. There was no evidence of the quadratic function after fitting the same model with systolic blood pressure. Methodological issues involved in studying a particular degree of blood pressure reduction were considered. The confidence interval around the change corresponding to the minimum hazard ratio was wide, and the obtained blood pressure level should not be interpreted as a goal for treatment. Blood pressure reduction was attributed not only to pharmacologic therapy but also to regression to the mean, and to other factors unrelated to treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3276167     DOI: 10.1093/oxfordjournals.aje.a114812

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  The J-curve interpreted. An alternative explanation of the results.

Authors:  M A Sekeres; J T Farrar; B L Strom
Journal:  J Gen Intern Med       Date:  1996-06       Impact factor: 5.128

2.  Diastolic blood pressure and the risk of primary cardiac arrest among pharmacologically treated hypertensive patients.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; L Cobb; P M Rautaharju; E H Wagner
Journal:  J Gen Intern Med       Date:  1996-06       Impact factor: 5.128

Review 3.  J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?

Authors:  Nicolás Roberto Robles; Francesco Fici; Guido Grassi
Journal:  J Nephrol       Date:  2018-09-17       Impact factor: 3.902

4.  Coronary flow reserve and the J curve.

Authors:  J M Cruickshank
Journal:  BMJ       Date:  1989-02-18

5.  Predictors of mortality in very old subjects aged 80 years or over.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G Colangeli; G Di Menza; M Marchioro; A Mazza; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

Review 6.  The J-curve in hypertension.

Authors:  John Cruickshank
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 7.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

8.  Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.

Authors:  U Lindblad; L Råstam; L Rydén; J Ranstam; S O Isacsson; G Berglund
Journal:  BMJ       Date:  1994-03-12

Review 9.  How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?

Authors:  Hoon Young Choi; Hyeong Cheon Park; Sung Kyu Ha
Journal:  Electrolyte Blood Press       Date:  2014-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.